SCHEMBL3401635

SCHEMBL3401635

O=[N+]([O-])c1ccc2nc(NC3CCc4cc(F)ccc43)ccc2c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC6 Q9UBN7 1/20 0.37
HTR3E A5X5Y0 1/20 0.37
HTR3B O95264 1/20 0.37
ALDH1A1 P00352 1/20 0.37
CYP1A2 P05177 1/20 0.37
CYP3A4 P08684 1/20 0.37
SLC6A4 P31645 1/20 0.37
CYP2C19 P33261 1/20 0.37
THPO P40225 1/20 0.37
HTR3A P46098 1/20 0.37
HTR3D Q70Z44 1/20 0.37
HTR3C Q8WXA8 1/20 0.37
HTR1A P08908 1/20 0.37
IRAK4 Q9NWZ3 2/20 0.36
RIPK1 Q13546 1/20 0.36
CHRNB2 P17787 1/20 0.35
CHRNB4 P30926 1/20 0.35
CHRNA3 P32297 1/20 0.35
CHRNA4 P43681 1/20 0.35
MEN1 O00255 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3403294 0.86 MEN1 (0.43) HTR3EHTR3BALDH1A1CYP1A2CYP3A4
SCHEMBL4108967 0.86 MEN1 (0.43) HTR3EHTR3BALDH1A1CYP1A2CYP3A4
SCHEMBL3428702 0.81 HDAC6 (0.40) HDAC6CHRNB2CHRNB4CHRNA3CHRNA4
SCHEMBL3405685 0.81 HDAC6 (0.40) HDAC6CYP3A4SLC6A4CYP2C19MAPT
SCHEMBL3411331 0.80 HTR1A (0.38) HTR3EHTR3BALDH1A1CYP1A2CYP3A4
SCHEMBL3411133 0.79 HTR1A (0.49) ALDH1A1CYP3A4CYP2C19HTR1AMEN1
SCHEMBL4099205 0.78 TRPV1 (0.44) HDAC6ALDH1A1CHRNB2CHRNA4MEN1
SCHEMBL4111676 0.75 HDAC6 (0.39) HDAC6MAPT
SCHEMBL4111354 0.75 NAMPT (0.42) HDAC6CYP1A2CYP3A4CYP2C19
SCHEMBL3410007 0.74 HTR1A (0.44) HTR3EHTR3BALDH1A1CYP1A2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8188284-B2 2-aminoquinolines HOFFMAN-LA ROCHE INC. (US) 2012-05-29 US disclosed
EP-2252372-A1 2-AMINOQUINOLINES F. Hoffmann-La Roche AG (CH) 2010-11-24 EP disclosed
WO-2009109502-A1 2-AMINOQUINOLINES F. HOFFMANN-LA ROCHE AG (CH) 2009-09-11 WO disclosed
US-20090227583-A1 2-AMINOQUINOLINES F. HOFFMANN-LA ROCHE AG, A SWISS COMPANY (CH) 2009-09-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090227583-A1 2-AMINOQUINOLINES HTR5A, HTR2C, HTR2B HDAC6 884/4885HTR3E 24/4885HTR3B 5/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.